![John McHutchison](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John McHutchison
Direktor/Vorstandsmitglied bei
ASSEMBLY BIOSCIENCES, INC.
Vermögen: 460 718 $ am 31.07.2026
Profil
Dr. John G.
McHutchison, MD, is a Chairman & Chief Executive Officer at Tune Therapeutics, Inc. and a Member at The Royal Australasian College of Physicians.
He is on the Board of Directors at Actio Biosciences, Inc., Evox Therapeutics Ltd. and Assembly Biosciences, Inc. Dr. McHutchison was previously employed as a President & Chief Executive Officer by Velia, Inc., an Independent Director by Metacrine, Inc., a Chief Scientific Officer, Head-R&D by Gilead Sciences, Inc., an Associate Director by Duke Clinical Research Institute, a Professor by Duke University Medical Center, a Medical Director-Liver Transplantation by Scripps Clinic & Research Foundation, and an Assistant Professor by University of Southern California.
He also served on the board at Oxford BioTherapeutics Ltd. He received his undergraduate degree from the University of Melbourne and a doctorate degree from the University of Melbourne.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.06.2026 | 18’348 ( 0.12% ) | 460 718 $ | 31.07.2026 |
Aktive Positionen von John McHutchison
| Unternehmen | Position | Beginn |
|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 06.08.2019 |
The Royal Australasian College of Physicians
 The Royal Australasian College of Physicians The non-profit company is based in Sydney, Australia. The Royal Australasian College of Physicians (RACP) is a professional organization representing over 30,000 medical specialists and trainees across 33 specialties in Australia and Aotearoa. It provides education and training pathways for physicians and paediatricians, including basic and advanced training, examinations, accreditation of training sites, and continuing professional development. The college supports diverse training environments through programs such as the Specialist Training Program, which promotes rural, private, and indigenous health service placements. RACP emphasizes indigenous health equity and cultural safety, advocates for healthcare policy, ethics, diversity, and gender equity, and engages members through committees and special interest groups. The organization invests in modernizing its infrastructure with initiatives like a new training management platform and a member relationship management system. It offers wellbeing resources, including a confidential 24/7 support program for counseling and coaching. Through the RACP Foundation, the college advances medical research and education by awarding fellowships, scholarships, grants, and prizes to support career development, research projects, and professional growth. The foundation and college also conduct educational research and evaluation to improve training quality and healthcare outcomes. The Royal Australasian College of Physicians was founded in 1938. | Corporate Officer/Principal | - |
Evox Therapeutics Ltd.
 Evox Therapeutics Ltd. BiotechnologyHealth Technology Develops transformational therapeutics | Direktor/Vorstandsmitglied | 18.01.2021 |
Tune Therapeutics, Inc.
 Tune Therapeutics, Inc. BiotechnologyHealth Technology Operates epigenome treatment medicines | Vorstandsvorsitzender | 01.03.2025 |
Actio Biosciences, Inc.
 Actio Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Gründer | 01.10.2021 |
Ehemalige bekannte Positionen von John McHutchison
| Unternehmen | Position | Ende |
|---|---|---|
Velia, Inc.
 Velia, Inc. Packaged SoftwareTechnology Services Provides software development services | Vorstandsvorsitzender | 01.03.2025 |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops antibody-based medicines for oncology | Direktor/Vorstandsmitglied | 24.04.2023 |
| METACRINE, INC. | Direktor/Vorstandsmitglied | 23.03.2023 |
| GILEAD SCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.08.2019 |
| ░░░░░░░ ░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von John McHutchison
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
69
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops antibody-based medicines for oncology | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke Clinical Research Institute
 Duke Clinical Research Institute Pharmaceuticals: OtherHealth Technology Manufactures medical and botanical products | Health Technology |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University Medical Center
 Duke University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scripps Clinic & Research Foundation | |
The Royal Australasian College of Physicians
The Royal Australasian College of Physicians The non-profit company is based in Sydney, Australia. The Royal Australasian College of Physicians (RACP) is a professional organization representing over 30,000 medical specialists and trainees across 33 specialties in Australia and Aotearoa. It provides education and training pathways for physicians and paediatricians, including basic and advanced training, examinations, accreditation of training sites, and continuing professional development. The college supports diverse training environments through programs such as the Specialist Training Program, which promotes rural, private, and indigenous health service placements. RACP emphasizes indigenous health equity and cultural safety, advocates for healthcare policy, ethics, diversity, and gender equity, and engages members through committees and special interest groups. The organization invests in modernizing its infrastructure with initiatives like a new training management platform and a member relationship management system. It offers wellbeing resources, including a confidential 24/7 support program for counseling and coaching. Through the RACP Foundation, the college advances medical research and education by awarding fellowships, scholarships, grants, and prizes to support career development, research projects, and professional growth. The foundation and college also conduct educational research and evaluation to improve training quality and healthcare outcomes. The Royal Australasian College of Physicians was founded in 1938. | |
Assembly Biosciences, Inc.
 Assembly Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of products for infectious diseases | Health Technology |
Metacrine, Inc.
 Metacrine, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in discovery and development of therapies for patients with liver and gastrointestinal diseases | Health Technology |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Develops transformational therapeutics | Health Technology |
Tune Therapeutics, Inc.
Tune Therapeutics, Inc. BiotechnologyHealth Technology Operates epigenome treatment medicines | Health Technology |
Velia, Inc.
Velia, Inc. Packaged SoftwareTechnology Services Provides software development services | Technology Services |
Actio Biosciences, Inc.
Actio Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Health Technology |
